Natural killer cells have an activated profile in early Parkinson's disease
Open Access
- 24 July 2023
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 382, 578154
Abstract
No abstract availableKeywords
Funding Information
- NIHR Cambridge Biomedical Research Centre (NIHR203312)
- UK Research and Innovation
- University of Cambridge Cambridge Centre for Parkinson-Plus
- Medical Research Council (MR/R007446/1)
- Research Councils UK
This publication has 27 references indexed in Scilit:
- Sex differences in immune responsesNature Reviews Immunology, 2016
- Parkinson's diseaseThe Lancet, 2015
- Regulation of Ligands for the NKG2D Activating ReceptorAnnual Review of Immunology, 2013
- Reduced T helper and B lymphocytes in Parkinson's diseaseJournal of Neuroimmunology, 2012
- Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's diseaseGeriatrics & Gerontology International, 2011
- Mutations inLRRK2increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal deathHuman Mutation, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Association of the human leucocyte antigen region with susceptibility to Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Natural killer cells of Parkinson's disease patients are set up for activation: A possible role for innate immunity in the pathogenesis of this diseaseParkinsonism & Related Disorders, 2008
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998